22-Jan-2026
No headlines found.
Business Wire (Mon, 12-Jan 6:15 AM ET)
Kevin Guest Returns to USANA Health Sciences as CEO
Business Wire (Thu, 8-Jan 9:00 AM ET)
USANA Executive Chairman Kevin Guest Shares Timeless Lessons for a 2026 Growth Mindset
PRNewswire (Mon, 5-Jan 7:13 AM ET)
USANA Foundation Shares Holiday Cheer with Meals for Utah Students and Families
PRNewswire (Tue, 23-Dec 6:52 AM ET)
Trust Your Gut--USANA's Probiotic Earns ConsumerLab.com Seal of Approval
PRNewswire (Tue, 16-Dec 7:20 AM ET)
Sidoti Events, LLC's Year-End Virtual Investor Conference
ACCESS Newswire (Tue, 9-Dec 12:48 PM ET)
USANA Extends Partnership with World-Famous Jamaican Bobsled Team to Help Fuel Their Olympic Dreams
PRNewswire (Thu, 4-Dec 7:07 AM ET)
PRNewswire (Wed, 3-Dec 7:03 AM ET)
Proven Power for Strong Bone Support--USANA's MagneCal D Earns ConsumerLab.com Seal of Approval
PRNewswire (Tue, 11-Nov 7:25 AM ET)
PRNewswire (Thu, 6-Nov 7:39 AM ET)
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
Usana Health Sciences trades on the NYSE stock market under the symbol USNA.
As of January 22, 2026, USNA stock price climbed to $22.51 with 102,912 million shares trading.
USNA has a beta of 1.11, meaning it tends to be more sensitive to market movements. USNA has a correlation of 0.16 to the broad based SPY ETF.
USNA has a market cap of $411.30 million. This is considered a Small Cap stock.
Last quarter Usana Health Sciences reported $214 million in Revenue and -$.15 earnings per share. This fell short of revenue expectation by $-207,600 and met earnings estimates .
In the last 3 years, USNA traded as high as $69.60 and as low as $18.48.
The top ETF exchange traded funds that USNA belongs to (by Net Assets): VTI, IWM, FNDA, AVUV, VDC.
USNA has underperformed the market in the last year with a return of -34.5%, while SPY returned +15.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in USNA shares. However, USNA has outperformed the market in the last 3 month and 2 week periods, returning +7.0% and +15.0%, while SPY returned +2.9% and -0.1%, respectively. This indicates USNA has been having a stronger performance recently.
USNA support price is $21.66 and resistance is $22.82 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that USNA shares will trade within this expected range on the day.